More importantly, it is possible to conclude that by combining PM, drugs and Ab-SMC2, we can make an important contribution, not only to the treatment of the primary tumor, but also in the eradication of the CSC population responsible for tumor recurrence and the metastatic spread of the disease. Here, SMC2 is linked to neoplasm.